期刊文献+

Matriptase-2多克隆抗体的制备及鉴定

Generation and Identifi cation of a Polyclonal Antibody to Matripase-2
下载PDF
导出
摘要 目的:探讨Matriptase-2重组蛋白的表达及多克隆抗体制备。方法 Matriptase-2胞外区近跨膜段(Glu81-Gly228)克隆入pMAL-C2X,重组质粒转化BL21(DE3)大肠杆菌,经IPTG诱导表达,提取细菌蛋白后用直链淀粉树脂纯化柱进行纯化。将纯化后的融合蛋白免疫新西兰大白兔,制备Matriptase-2抗血清;免疫血清用protein G亲和层析柱进行纯化,获得多克隆抗体。结果成功表达了Matriptase-2重组融合蛋白,获得了高效价的抗血清,Western blot结果显示具有抗原特异性识别。结论成功制备了高特异性、高效价的抗人Matriptase-2多克隆抗体,为今后深入研究Matriptase-2的生物学功能提供了有用的实验工具。 Objective To investigate the expression of Matriptase-2 recombinant protein inE.coli and the generation of its polyclonal antibody.Methods Extracellular region (Glu81-Gly228) proximal to transmembrane domain of Matriptase-2 was cloned into pMAL-C2X. The recombinant plasmid was transformed to BL21 (DE3) bacteria. After IPTG induction, the total protein was extracted and the recombinant Matriptase-2 protein was purifi ed with amylose resin. The Matriptase-2 recombinant protein was used to immunize New Zealand Rabbits to prepare serum with anti-Matriptase-2 polyclonal antibody. The antibody was purifi ed from serum by protein G sepharose 4B.Results Recombinant Matriptase-2 protein was successfully expressed inE.coliand anti-serum with high titer was obtained. Western blotting result showed that the antibody specifi cally recognized Matriptase-2. Conclusion It is concluded that the anti-Matriptase-2 polyclonal antibody with high titer and specificity is successfully generated. The antibody provides an useful experimental tool to investigate the biological function of Matriptase-2.
出处 《中国血液流变学杂志》 CAS 2014年第4期472-475,共4页 Chinese Journal of Hemorheology
基金 江苏省高校优势学科建设工程资助项目 江苏省临床医学中心项目(ZX201102)
关键词 Matriptase-2 原核表达 多克隆抗体 Matriptase-2 prokaryotic expression polyclonal antibody
  • 相关文献

参考文献9

  • 1Velasco G, Cal S, Quesada V, et al. Matriptase-2, a membrane-bound mosaic serine proteinase predominantly expressed in human liver and showing degrading activity against extracellular matrix proteins[J]. J Biol Chem, 2002, 277(40): 37637 - 37646.
  • 2Ramsay AJ, Hooper JD, Folgueras AR, et al. Matriptase-2 (TMPRSS6): a proteolytic regulator of iron homeostasis[J]. Haematologica, 2009, 94(6): 840 - 849.
  • 3Du X, She E, Gelbart T, et al. The serine protease TMPRSS6 is required to sense iron deficiency[J]. Science, 2008, 320(5879): 1088 - 1092.
  • 4Parr C, Sanders A J, Davies G, et al. Matriptase-2 inhibits breast tumor growth and invasion and correlates with favorable prognosis for breast cancer patients[J]. Clin Cancer Res, 2007, 13(12): 3568 - 3576.
  • 5Sanders A J, Parr C, Martin TA, et al. Genetic upregulation of matriptase-2 reduces the aggressiveness of prostate cancer cells in vitro and in vivo and affects FAK and paxillin localisation[J]. J Cell Physiol, 2008, 216(3): 780 - 789. J.
  • 6iang J, Yang J, Feng P, et al. N-glycosylation is required for matriptase-2 autoactivation and ectodomain shedding[J]. J Biol Chem, 2014, 289(28): 19500 - 19507.
  • 7Bugge TH, Antalis TM, Wu Q. Type Ⅱ transmembrane serine proteases[J]. J Biol Chem, 2009, 284(35): 23177 - 23181.
  • 8Silvestri L, Pagani A, Nai A, et al. The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin[J]. Cell Metab, 2008, 8(6): 502 - 511.
  • 9Finberg KE, Whittlesey RL, Fleming MD, et al. Down- regulation of Bmp/Smad signaling by Tmprss6 is required for maintenance of systemic iron homeostasis[J]. Blood, 2010, 115(18): 3817 - 3826.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部